Emgality 120 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26F5Z65
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,674
Award facts
- Contract value 100% obligated
- $1,674.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,674.00 delivery order to AmerisourceBergen Drug Corp for the supply of Emgality 120 mg/mL pen injectors. This firm fixed-price, non-set-aside contract was awarded on January 23, 2026, with an ultimate completion date of January 26, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, through its parent company Cencora, is a major pharmaceutical distributor providing critical medical commodities to federal agencies, including the Defense Health Agency and U.S. Coast Guard. Emgality is a CGRP receptor antagonist used for migraine prevention, reflecting the company's ongoing role in supplying specialized pharmaceutical treatments across multiple therapeutic domains to military healthcare systems. The rapid completion timeline indicates this is a routine replenishment order under the established DLA Medical Supply Chain framework, demonstrating the efficiency of the indefinite delivery contract vehicle in fulfilling urgent medical supply requirements for federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F5Z65?
SPE2DR26F5Z65 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F5Z65 worth?
The government has obligated $1,674 on SPE2DR26F5Z65.
Is contract SPE2DR26F5Z65 an order under another contract?
Yes. SPE2DR26F5Z65 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5Z65 competed?
The extent of competition for SPE2DR26F5Z65 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award